You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 111 No. 1, January 1966 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (34)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Vincristine Sulfate in the Treatment of Neuroblastoma in Children

A Cooperative Study

JOAN WINDMILLER CHAIRMAN, MD; D. H. BERRY, MD; T. B. HADDY, MD; T. J. VIETTI, MD; W. W. SUTOW, MD

Am J Dis Child. 1966;111(1):75-78.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

VINCRISTINE sulfate, an alkaloid of the periwinkle plant, was made available for clinical use in 1961. Early data suggested activity of this drug in the treatment of children with acute leukemia1-3 and a variety of solid tumors.4-6 In children with generalized neuroblastoma, one of three reported by Selawry and Hananian4 and three of seven children studied by James and George5 demonstrated favorable tumor response to vincristine. The effectiveness of vincristine in children with generalized neuroblastoma was investigated by a co-operative protocol study of the Pediatric Division of the Southwest Cancer Chemotherapy Study Group. The results of this study constitute the basis for this preliminary report.

Materials and Methods

Twenty children under 15 years of age with a tissue diagnosis of neuroblastoma were registered for the study within a 25-month period. Criteria for admission into this study included measurable lesions with evidence of progressive disease no longer . . . [Full Text PDF of this Article]


Footnotes



Received for publication June 30, 1965.

This is a report of the Committee of the Pediatric Division of the Southwest Cancer Chemotherapy Study Group. For a complete list of participants see the footnote at the end of the communication.

Reprint requests to Department of Pediatrics, University of Texas Southwestern Medical School, 5323 Harry Hines Blvd, Dallas 75235 (Dr. Windmiller).

Died one month later.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.